GSK Pak begins new packaging technology
LAHORE: Adhering to their commitment to innovation, GSK Pakistan has introduced a specialized form of blister packaging technology in the country. After being supplied in glass bottles for 34 years, Pakistan's leading antibiotic, Augmentin, will now be available indessiflex packaging, says a Press release.
Co-amoxiclav, or Augmentin, is highly sensitive to moisture, and given GSK's standards of quality, conventional blister packaging proved insufficient to maintain the necessary efficacy of the drug.
In a pioneering step, which involved an investment of Rs. 74 million, GSK Pakistan also became the first site to introduce this technology in its global network. Dessiflex technology uses a layer of micro-desiccant particles to provide enhanced protection for moisture sensitive tablets, like Augmentin. For patients, in addition to ensuring uncompromised quality, dessiflex blister packaging will also provide easier dose tracking, more safety, and greater convenience as compared to bottles.
Speaking on this occasion, CEO GSK Pakistan, Muhammad Azizul Huq, says, "Along with the benefits to our patients, GSK Pakistan is proud to be the first country in the GSK network to introduce dessiflex technology, and we look forward to transferring expertise to the rest of our global markets."